Fierce Biotech Mix Logo.png Fierce Biotech Mix Logo.png
Webinar

Protecting Endpoint Integrity Through Behavior-Informed eCOA Design and Monitoring

Available on-demand
60 Minutes

As eCOA adoption expands, standardized approaches may introduce risks to scientific rigor and endpoint integrity. Join this insightful session to examine how behavior-informed design, grounded in real-world patient use, and proactive monitoring can help address those risks. 

We’ll explore: 

  • How patient behavior and real-world use should inform eCOA design 

  • Ways proactive monitoring can identify compliance and data-quality risks earlier 

  • Strategies for strengthening endpoint integrity and generating more reliable clinical outcomes

Speakers

0

Melissa Mooney

Melissa Mooney has over 20 years of experience in the development of eCOA solutions for use in clinical trials. Melissa’s area of expertise is eCOA solution design where she has supported clients and eCOA vendors in developing robust and usable eCOA software solutions that meet eCOA protocol requirements. She also brings extensive experience in eCOA requirements gathering, leading eCOA User Acceptance Testing, eCOA data management, and business development support.

image_24.png

Lindsay Hughes

Lindsay Hughes is a Principal within IQVIA’s Patient Centered Solutions team with nearly 20 years of experience in behavioral and life sciences, focusing on the role of information and human behavior in health outcomes. She leads a team that supports pharma clients in implementing digital measures in clinical research and healthcare settings.

Register here to watch on-demand!